- Home
- EWTX vs SA Comparison
EWTX vs SA Comparison
Compare EWTX & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- SA
- Stock Information
- Founded
- EWTX 2017
- SA 1979
- Country
- EWTX United States
- SA Canada
- Employees
- EWTX N/A
- SA N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- SA Precious Metals
- Sector
- EWTX Health Care
- SA Basic Materials
- Exchange
- EWTX Nasdaq
- SA Nasdaq
- Market Cap
- EWTX 1.2B
- SA 1.0B
- IPO Year
- EWTX 2021
- SA N/A
- Fundamental
- Price
- EWTX $14.58
- SA $12.62
- Analyst Decision
- EWTX Buy
- SA
- Analyst Count
- EWTX 8
- SA 0
- Target Price
- EWTX $40.13
- SA N/A
- AVG Volume (30 Days)
- EWTX 1.2M
- SA 720.3K
- Earning Date
- EWTX 05-08-2025
- SA 05-20-2025
- Dividend Yield
- EWTX N/A
- SA N/A
- EPS Growth
- EWTX N/A
- SA N/A
- EPS
- EWTX N/A
- SA N/A
- Revenue
- EWTX N/A
- SA N/A
- Revenue This Year
- EWTX N/A
- SA N/A
- Revenue Next Year
- EWTX N/A
- SA N/A
- P/E Ratio
- EWTX N/A
- SA N/A
- Revenue Growth
- EWTX N/A
- SA N/A
- 52 Week Low
- EWTX $10.60
- SA $9.40
- 52 Week High
- EWTX $38.12
- SA $20.55
- Technical
- Relative Strength Index (RSI)
- EWTX 41.67
- SA 55.76
- Support Level
- EWTX $13.82
- SA $12.19
- Resistance Level
- EWTX $17.30
- SA $13.05
- Average True Range (ATR)
- EWTX 1.02
- SA 0.43
- MACD
- EWTX 0.32
- SA -0.00
- Stochastic Oscillator
- EWTX 30.43
- SA 65.87
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.